Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

84.67 -0.67 (-0.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
34 35 Next >
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
Last year wasn't great for either stock, but that's no reason to ignore them. 
Via The Motley Fool
History Says the Nasdaq Will Soar in 2024: 1 Stock-Split AI Growth Stock to Buy Now and Hold Forever
Nvidia is well positioned to create value for patient shareholders, given its leadership in artificial intelligence chips. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks to Capitalize on the Telehealth Explosion
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic. 
Via InvestorPlace
Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales
Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance. 
Via Investor's Business Daily
A Closer Look at DexCom's Options Market Dynamics
Via Benzinga
Is NASDAQ:DXCM a Fit for Growth Investing Strategies?
Should you consider DEXCOM INC (NASDAQ:DXCM) for growth investing? 
Via Chartmill
The Latest Analyst Ratings For DexCom
Via Benzinga
DexCom Unusual Options Activity
Via Benzinga
Looking Into DexCom's Recent Short Interest
Via Benzinga
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
From DexCom, Inc.
Via Business Wire
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an... 
Via The Motley Fool
$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today
Via Benzinga
DexCom's Options Frenzy: What You Need to Know
Via Benzinga
For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering.
NASDAQ:DXCM stands out as a growth opportunity that won't break the bank. 
Via Chartmill
These 3 Companies Can Be the Next Stock-Split Stocks in 2024
Since mid-2021, Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk have conducted stock splits. Three well-known companies look set to follow in... 
Via The Motley Fool
Meet the Stock-Split Stock Warren Buffett Is Likeliest to Buy in 2024
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a stock-split stock that checks all the right boxes for the Oracle of Omaha. 
Via The Motley Fool
3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for... 
Via The Motley Fool
DEXCOM INC (NASDAQ:DXCM) showing high EPS and FCF growth while beating expectations
DEXCOM INC (NASDAQ:DXCM) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating. 
Via Chartmill
NASDAQ:DXCM is showing decent growth, but is still valued reasonably.
NASDAQ:DXCM is not too expensive for the growth it is showing. 
Via Chartmill
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three high-flying stocks a trio of Wall Street analysts believe can soar in the... 
Via The Motley Fool
Pet Parents Keep Spending
We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care. 
Via The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today
Via Benzinga
(DXCM) - Analyzing DexCom's Short Interest
Via Benzinga
Market Whales and Their Recent Bets on DXCM Options
Via Benzinga
Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
From DexCom, Inc.
Via Business Wire
DexCom Stock Earns Healthy Relative Strength Rating Upgrade
In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday. 
Via Investor's Business Daily
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.